Dan Shu

6.6k total citations
118 papers, 4.0k citations indexed

About

Dan Shu is a scholar working on Molecular Biology, Ecology and Cancer Research. According to data from OpenAlex, Dan Shu has authored 118 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 20 papers in Ecology and 17 papers in Cancer Research. Recurrent topics in Dan Shu's work include RNA Interference and Gene Delivery (38 papers), Advanced biosensing and bioanalysis techniques (37 papers) and Bacteriophages and microbial interactions (20 papers). Dan Shu is often cited by papers focused on RNA Interference and Gene Delivery (38 papers), Advanced biosensing and bioanalysis techniques (37 papers) and Bacteriophages and microbial interactions (20 papers). Dan Shu collaborates with scholars based in China, United States and Germany. Dan Shu's co-authors include Peixuan Guo, Farzin Haque, Yi Shu, Gaofeng Xiong, Ren Xu, B. Mark Evers, Hongran Yin, Yi Shu, Hui Zhang and Fengmei Pi and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Advanced Materials.

In The Last Decade

Dan Shu

110 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Shu China 35 3.2k 671 661 477 318 118 4.0k
Souvik Maiti India 43 4.3k 1.4× 621 0.9× 239 0.4× 349 0.7× 286 0.9× 182 5.6k
Minghui Liu China 32 4.1k 1.3× 648 1.0× 626 0.9× 1.1k 2.3× 236 0.7× 94 4.8k
Rakesh N. Veedu Australia 32 3.6k 1.1× 649 1.0× 193 0.3× 698 1.5× 192 0.6× 114 4.2k
Jeehyeon Bae South Korea 32 1.9k 0.6× 302 0.5× 136 0.2× 293 0.6× 136 0.4× 106 3.2k
Rodrigo Barderas Spain 37 2.8k 0.9× 499 0.7× 179 0.3× 912 1.9× 67 0.2× 182 4.5k
Marina A. Zenkova Russia 29 2.8k 0.9× 499 0.7× 134 0.2× 137 0.3× 208 0.7× 287 3.6k
Hyesung Jeon South Korea 31 2.3k 0.7× 278 0.4× 100 0.2× 568 1.2× 832 2.6× 69 4.0k
Luca Domenico D’Andrea Italy 26 2.1k 0.7× 188 0.3× 103 0.2× 219 0.5× 362 1.1× 90 3.0k
Carston R. Wagner United States 36 2.6k 0.8× 221 0.3× 112 0.2× 251 0.5× 323 1.0× 129 3.8k

Countries citing papers authored by Dan Shu

Since Specialization
Citations

This map shows the geographic impact of Dan Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Shu more than expected).

Fields of papers citing papers by Dan Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Shu. The network helps show where Dan Shu may publish in the future.

Co-authorship network of co-authors of Dan Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Shu. A scholar is included among the top collaborators of Dan Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Shu. Dan Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shu, Dan, Samantha Pang, Li Wang, et al.. (2025). Primary caregiver-reported family resilience in children with cancer in central China: a latent profile analysis. BMC Nursing. 24(1). 1248–1248.
3.
Lu, Meng, Yumin Zhang, Ya-Wei Guo, et al.. (2024). Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagy. Cancer Letters. 600. 217161–217161. 12 indexed citations
4.
Li, Kang, Dan Shu, & Li Han. (2024). Abstract PO2-23-11: SMAD4 depletion contributes to endocrine therapy resistance by ERBB signaling in HR+HER2- breast cancer. Cancer Research. 84(9_Supplement). PO2–23.
5.
Pan, Tingting, et al.. (2024). Mediator Effects of Cognitive Load on Association between Self-Efficacy and Task Load in Intensive Care Unit Nurses. Journal of Nursing Management. 2024. 1–7. 2 indexed citations
6.
Shu, Dan, Zhemin Li, Di Luo, et al.. (2024). Screening and stability verification of reference genes in Botrytis cinerea ZX2 fermentation. Preparative Biochemistry & Biotechnology. 55(3). 341–348.
7.
Shu, Dan, Han Li, Wenjie Zhang, et al.. (2024). SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2− breast cancer. Cell Death and Disease. 15(6). 444–444. 7 indexed citations
8.
Chen, Dongbo, Dan Shu, Wei Zhao, et al.. (2023). Combined transcriptome and proteome analysis of Bcfrp1 involved in regulating the biosynthesis of abscisic acid and growth in Botrytis cinerea TB-31. Frontiers in Microbiology. 13. 1085000–1085000. 9 indexed citations
9.
Xu, Yingkun, Han Li, Zhenrong Tang, et al.. (2022). Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Journal of Oncology. 2022. 1–15. 17 indexed citations
10.
Xu, Yingkun, Dan Shu, Meiying Shen, et al.. (2022). Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer. Journal of Immunology Research. 2022. 1–22. 9 indexed citations
12.
Chen, Xu, Hanbin Wang, Houzhao Wan, et al.. (2018). Core/shell Cu/FePtCu nanoparticles with face-centered tetragonal texture: An active and stable low-Pt catalyst for enhanced oxygen reduction. Nano Energy. 54. 280–287. 26 indexed citations
13.
Shu, Yi, Hongran Yin, Mehdi Rajabi, et al.. (2018). RNA-based micelles: A novel platform for paclitaxel loading and delivery. Journal of Controlled Release. 276. 17–29. 49 indexed citations
14.
Smith, Jayden A., Alice Braga, Clara Alfaro‐Cervelló, et al.. (2017). RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity. Molecular Therapy — Nucleic Acids. 10. 103–121. 18 indexed citations
15.
Wang, Hanbin, Xu Chen, Dan Shu, et al.. (2016). Effect of Cu doping on the structure and phase transition of directly synthesized FePt nanoparticles. Journal of Magnetism and Magnetic Materials. 422. 470–474. 19 indexed citations
16.
Shu, Yi, Fengmei Pi, Ashwani Sharma, et al.. (2013). Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Advanced Drug Delivery Reviews. 66. 74–89. 204 indexed citations
17.
Haque, Farzin, Dan Shu, Yi Shu, et al.. (2012). Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today. 7(4). 245–257. 154 indexed citations
18.
Shu, Dan, et al.. (2010). New insights on the formation of magmatic sulfide deposits in magma conduit system.. Dixue qianyuan. 17(1). 153. 3 indexed citations
19.
Li, Li, et al.. (2009). Evaluation of specific delivery of chimeric phi29 pRNA/siRNAnanoparticles to multiple tumor cells. Molecular BioSystems. 5(11). 1361–1368. 33 indexed citations
20.
Lü, Yinhua, Weihua Wang, Dan Shu, et al.. (2007). Characterization of a novel two-component regulatory system involved in the regulation of both actinorhodin and a type I polyketide in Streptomyces coelicolor. Applied Microbiology and Biotechnology. 77(3). 625–635. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026